Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chryssi Frangiadaki"'
Autor:
Vassilis Georgoulias, G. Retalis, Stelios Kakolyris, Efthimios Sivridis, Michael I. Koukourakis, Chryssi Frangiadaki, Alexandra Giatromanolaki, Charalambos Kouroussis
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 52:144-155
Although the role of radiotherapy (RT) after mastectomy in reducing the local relapse rate is well established, its impact on overall survival is strongly questioned. Up to 70% of patients will not benefit from additional RT, and a "wait and see" pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8afda0930fce9620d1b16084c2100b8
https://doi.org/10.1016/s0360-3016(01)01759-x
https://doi.org/10.1016/s0360-3016(01)01759-x
Autor:
Emmanuel S. Helidonis, Irene Stefanaki, Eugenios Koumandakis, Alexandra Giatromanolaki, Angelos Kranidis, V. Georgoulias, Athena Armenaki, Michael I. Koukourakis, Chryssi Frangiadaki
Publikováno v:
American Journal of Clinical Oncology. 21:595-601
Carboplatin is one of the most common drugs used for radiochemotherapy of cancer. However, the best way to combine the drug with fractionated radiotherapy has not been established. In the present study the authors investigated which maximum tolerated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137c467d288686a8b4e79e731b07c211
https://doi.org/10.1097/00000421-199812000-00013
https://doi.org/10.1097/00000421-199812000-00013
Autor:
Michael I. Koukourakis, Chryssi Frangiadaki, G. Retalis, Stelios Kakolyris, Alexandra Giatromanolaki, Vassilios Georgoulias, Charalambos Kouroussis, George Kyrias
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18(11)
PURPOSE: Amifostine (WR-2721) is an impotant cytoprotective agent. Although intravenous administration is the standard route, pharmacokinetic studies have shown acceptable plasma levels of the active metabolite of amifostine (WR-1605) after subcutane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7dddb7034a1faf8a83c772a091f4d92
https://pubmed.ncbi.nlm.nih.gov/11230504
https://pubmed.ncbi.nlm.nih.gov/11230504
Autor:
G. Retalis, Michael I. Koukourakis, V. Georgoulias, E. Sivridis, S. Kakolyris, A. Giatromanolaki, Chryssi Frangiadaki, Ch. Kouroussis
Publikováno v:
European Journal of Cancer. 37:S173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cd3a84dc3b0b99d6ab8d955daa0af6d
https://doi.org/10.1016/s0959-8049(01)81124-2
https://doi.org/10.1016/s0959-8049(01)81124-2
Autor:
G. Retalis, Stelios Kakolyris, V. Georgoulias, Alexandra Giatromanolaki, Chryssi Frangiadaki, Charalambos Kouroussis, Michael I. Koukourakis, E. Garedaki
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 45:239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64d5edca29f907399a08a1738285851b
https://doi.org/10.1016/s0360-3016(99)90195-5
https://doi.org/10.1016/s0360-3016(99)90195-5